Next Article in Journal
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
Previous Article in Journal
Geraniol-Mediated Suppression of Endoplasmic Reticulum Stress Protects against Cerebral Ischemia–Reperfusion Injury via the PERK-ATF4-CHOP Pathway
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2023, 24(1), 541; https://doi.org/10.3390/ijms24010541
Action Date Notes Link
article xml file uploaded 29 December 2022 07:31 CET Original file -
article xml uploaded. 29 December 2022 07:31 CET Update https://www.mdpi.com/1422-0067/24/1/541/xml
article pdf uploaded. 29 December 2022 07:31 CET Version of Record https://www.mdpi.com/1422-0067/24/1/541/pdf
article supplementary file uploaded. 29 December 2022 07:31 CET - https://www.mdpi.com/1422-0067/24/1/541#supplementary
article html file updated 29 December 2022 07:32 CET Original file -
article html file updated 1 March 2023 06:41 CET Update -
article html file updated 5 March 2023 01:25 CET Update https://www.mdpi.com/1422-0067/24/1/541/html
Back to TopTop